What is China Shineway Pharmaceutical Group Limited (CSWYY)?

China Shineway Pharmaceutical Group Limited (CSWYY) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is CSWYY's price-to-earnings (PE) ratio?

CSWYY's trailing twelve-month PE ratio is 5.88, based on current price and earnings per share data available on Stocks360.

Does CSWYY pay a dividend?

Yes. CSWYY has a trailing twelve-month dividend yield of 0.33%. Dividend data is sourced from financial market providers and displayed on Stocks360.

China Shineway Pharmaceutical Group Limited (CSWYY)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

Market Cap

N/A

PE (TTM)

5.88

EPS (TTM)

N/A

Dividend Yield

33.22%

Beta

0.72

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

China Shineway Pharmaceutical Group Limited (CSWYY) is a publicly traded company in the Healthcare sector. Trailing PE 5.88. Dividend yield 33.22%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 6 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-29 · $19.25 2026-10-26 · $16.79 (-12.78%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About China Shineway Pharmaceutical Group Limited

As an investment holding company, China Shineway Pharmaceutical Group Limited primarily focuses on the research, development, production, and commercialization of traditional Chinese medicines across mainland China and Hong Kong. Its product portfolio encompasses contemporary Chinese medicines delivered as soft capsules, granules, and injectable solutions. Additionally, it provides specialized TCM Formula Granules, addressing a broad spectrum of medical conditions such as cardiovascular and cerebrovascular issues, viral infections, orthopedic complaints, pediatric ailments, gynecological disorders, and gastrointestinal problems. Beyond pharmaceuticals, the group also engages in the trading of agricultural commodities. Established in 2004, China Shineway Pharmaceutical Group Limited maintains its corporate headquarters in Shijiazhuang, within the People's Republic of China. The company operates as a subsidiary under the umbrella of Forway Investment Limited.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	5.88×
P/S (TTM)	1.76×
P/B	0.57×
P/FCF (TTM)	5.23×
EV / EBITDA	-3.23×
EV / Sales	-0.97×
Earnings Yield	17.11%
Free Cash Flow Yield	19.12%
Dividend Yield	33.22%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	-$2.56B
Net Income (TTM)	$797.97M
Free Cash Flow (TTM)	$893.06M
Net Debt	-$7.22B
Working Capital	$6.92B
Gross Margin	71.27%
Operating Margin	24.41%
Net Margin	30.14%
Return on Equity	9.81%
Return on Invested Capital	5.63%